Antimicrobial Resistance in Mycoplasma spp
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Mycoplasmas are intrinsically resistant to antimicrobials targeting the cell wall (fosfomycin, glycopeptides, or β-lactam antibiotics) and to sulfonamides, first-generation quinolones, trimethoprim, polymixins, and rifampicin. The antibiotics most frequently used to control mycoplasmal infections in animals are macrolides and tetracyclines. Lincosamides, fluoroquinolones, pleuromutilins, phenicols, and aminoglycosides can also be active. Standardization of methods used for determination of susceptibility levels is difficult since no quality control strains are available and because of species-specific growth requirements. Reduced susceptibility levels or resistances to several families of antimicrobials have been reported in field isolates of pathogenic Mycoplasma species of major veterinary interest: M. gallisepticum and M. synoviae in poultry; M. hyopneumoniae , M. hyorhinis , and M. hyosynoviae in swine; M. bovis in cattle; and M. agalactiae in small ruminants. The highest resistances are observed for macrolides, followed by tetracyclines. Most strains remain susceptible to fluoroquinolones. Pleuromutilins are the most effective antibiotics in vitro . Resistance frequencies vary according to the Mycoplasma species but also according to the countries or groups of animals from which the samples were taken. Point mutations in the target genes of different antimicrobials have been identified in resistant field isolates, in vitro -selected mutants, or strains reisolated after an experimental infection followed by one or several treatments: DNA-gyrase and topoisomerase IV for fluoroquinolones; 23S rRNA for macrolides, lincosamides, pleuromutilins, and amphenicols; 16S rRNAs for tetracyclines and aminoglycosides. Further work should be carried out to determine and harmonize specific breakpoints for animal mycoplasmas so that in vitro information can be used to provide advice on selection of in vivo treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Biology and Pathogenicity of Mycoplasmas
Razin, S., Yogev, D., & Naot, Y. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1094-1156.1998 · Cited by 1,930
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Brodersen, D. E., Clemons, W. M., Carter, A. P., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Cell · doi:10.1016/s0092-8674(00)00216-6 · Cited by 950 · cited 1×
“Their binding pocket is formed by an irregular minor grove of helix 34 (residues 1196 to 1200:1053 to 1056) in combination with residues 964 to 967 from the helix 31 stem-loop (130).”
BackgroundWang, C., Ewing, M., & A'arabi, S. Y. (2001) · Avian Diseases · doi:10.2307/1592988 · Cited by 34 · cited 1×
“Several studies report in vitro susceptibility levels of M. synoviae fi eld isolates (29, 32, 41, 47, 74 – 76, 81, 82) (Table 3).”
Background
Cited by
Andrés-Lasheras, S., Jelinski, M., Zaheer, R., & McAllister, T. A. (2022) · Antibiotics · doi:10.3390/antibiotics11040487 · Cited by 42
Genome Editing of Veterinary Relevant Mycoplasmas Using a CRISPR-Cas Base Editor System
Ipoutcha, T., Rideau, F., Gourgues, G., Arfi, Y., Lartigue, C., Blanchard, A., & Sirand-Pugnet, P. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.00996-22 · Cited by 19
“In the context of increasing antibiotic resistance (14) and the relative lack of effective vac-”
BackgroundTreatment of bovine respiratory disease with a single administration of tulathromycin and ketoprofen
De Koster, J., Tena, J., & Stegemann, M. R. (2022) · Veterinary Record · doi:10.1002/vetr.834 · Cited by 18
Malave-Ramos, D. R., Kennedy, K., Key, M. N., Dou, Z., & Kafsack, B. F. C. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.03497-22 · Cited by 4
“tetracyclines, macrolides, and quinolones (5).”
de Jong, A., Temmerman, R., Sweeney, M. T., & El Garch, F. (2025) · Antimicrobial Food Packaging · doi:10.1016/b978-0-323-90747-7.00010-7 · Cited by 1
Metadata
- Authors
- Gautier-Bouchardon, A. V.
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2018-07-27
- Volume
- 6
- Issue
- 4
- ISSN
- 2165-0497 (ISSN-L)
- OpenAlex
- W2883730734
- Cited by
- 207
- References
- 4
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.